1. miRNAs mediated drug resistance in hematological malignancies
   Sara Peixoto da Silva et al, 2022, Seminars in Cancer Biology CrossRef
2. Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance
   Huan Xiao et al, 2021, Frontiers in Pharmacology CrossRef
3. hsa-miR-9-3p and hsa-miR-9-5p as Post-Transcriptional Modulators of DNA Topoisomerase IIαin Human Leukemia K562 Cells with Acquired Resistance to Etoposide
   Evan E. Kania et al, 2020, Molecular Pharmacology CrossRef
4. Role of MicroRNAs in Cancer Drug Resistance
   Kondapalli N. Babu et al, 2022, Role of MicroRNAs in Cancers CrossRef
5. Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment
   Soudeh Ghafouri-Fard et al, 2021, Biomedicine & Pharmacotherapy CrossRef
6. MicroRNA-655-3p regulates Echinacea purpurea mediated activation of ABCG2
   Charles Awortwe et al, 2018, Xenobiotica CrossRef
7. Overexpression of miR‑574‑3p suppresses proliferation and induces apoptosis of chronic myeloid leukemia cells via targeting IL6/JAK/STAT3 pathway
   Haoying Yang et al, 2018, Experimental and Therapeutic Medicine CrossRef
8. Downregulation of SOX21-AS1 Alleviated Cisplatin Resistance in Cervical Cancer Through Epithelial–Mesenchymal Transition Inhibition
   Jing Tian et al, 2022, Rejuvenation Research CrossRef
9. ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia
   Simona Sucha et al, 2022, Biomedicine & Pharmacotherapy CrossRef
10. Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia
    Raquel Maia et al, 2018, Molecules CrossRef
11. The versatile nature of miR-9/9* in human cancer
    Katarzyna Nowek et al, 2018, Oncotarget CrossRef
12. Myeloid leukemia with high EVI1 expression is sensitive to 5-aza-2′-deoxycytidine by targeting miR-9
    F. Li et al, 2020, Clinical and Translational Oncology CrossRef
13. Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant
    Yan Liang et al, 2021, Journal of Controlled Release CrossRef
14. Emerging Effects of Sepantronium Bromide (YM155) on MOLT-4 Cell Line Apoptosis Induction and Expression of Critical Genes Involved in Apoptotic Pathways
    Kobra Shojaei Moghadam et al, 2019, Advanced Pharmaceutical Bulletin CrossRef
15. Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation
    Zsuzsanna Gaál, 2022, International Journal of Molecular Sciences CrossRef
16. MicroRNA-9-3p Aggravates Cerebral Ischemia/Reperfusion Injury by Targeting Fibroblast Growth Factor 19 (FGF19) to Inactivate GSK-3β/Nrf2/ARE Signaling
    Yadong Zhou et al, 2021, Neuropsychiatric Disease and Treatment CrossRef
17. Diverse Targeted Approaches to Battle Multidrug Resistance in Cancer
    Nagula Shankaraiah et al, 2019, Current Medicinal Chemistry CrossRef
18. MicroRNAs and response to therapy in leukemia
    Hossein Sharifi et al, 2019, Journal of Cellular Biochemistry CrossRef
19. Not only P-glycoprotein: Amplification of the ABCB1- containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins
    Ilaria Genovese et al, 2017, Drug Resistance Updates CrossRef
20. Oestrogen‐related receptor alpha mediates chemotherapy resistance of osteosarcoma cells via regulation of ABCB1
    Yantao Chen et al, 2019, Journal of Cellular and Molecular Medicine CrossRef